BioCentury
ARTICLE | Clinical News

Cenderitide: Phase I data

January 2, 2012 8:00 AM UTC

Top-line data from a placebo-controlled, U.S. Phase I trial in 58 patients with ADHF showed that subcutaneous infusions of cenderitide met the primary endpoint by achieving undisclosed target PK level...